| Bioactivity | hPL-IN-1 (compound 2t) is a reversible inhibitor of pancreatic lipase (PL) (IC50=1.86 μM) for anti-obesity research[1]. |
| Target | IC50: 1.86 μM (Pancreatic lipase, PL) |
| Name | hPL-IN-1 |
| CAS | 2387374-26-5 |
| Formula | C19H11Cl2F2NO3 |
| Molar Mass | 410.20 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhao Y, et al. Design, synthesis and biological evaluation of salicylanilides as novel allosteric inhibitors of human pancreatic lipase. Bioorg Med Chem. 2023 Aug 15;91:117413.. . |
hPL-IN-1
CAS: 2387374-26-5 F: C19H11Cl2F2NO3 W: 410.20
hPL-IN-1 (compound 2t) is a reversible inhibitor of pancreatic lipase (PL) (IC50=1.86 μM) for anti-obesity research.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.